20 completed, 4 terminated, 1 unknown. 25 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 25 | Completed 20, Terminated 4, Unknown 1 |
Follow epoetin beta: new trials by email Literature Review of epoetin beta trials Research Report on epoetin beta
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment Response in Dialysis Anaemia Iron sucrose, Erythopoietin stimulating agent - Anaemia, Haemodialysis | Phase 4 | Completed | Imperial College Healthcare NHS Trust | 197 | 2015-07-01 | 2021-04-14 |
| Predictors of Response to Iron and Erythropoietin Stimulating Agents Iron Sucrose Solution for Injection, Epoetin Beta - Renal Failure Chronic, Anemia | Phase 4 | Completed | Imperial College London | 197 | 2015-06-03 | 2019-07-05 |
| Paricalcitol Improves Anemia of Inflammation Paricalcitol, Epoetin beta, Placebo - Anemia | Phase 4 | Terminated | Hospital Son Espases | 19 | 2014-12-01 | 2024-12-09 |
| A Study of Epoetin Beta Treatment in Anemic Participants With Myelodysplastic Syndrome (MDS) Epoetin beta - Myelodysplastic Syndromes | Phase 4 | Completed | Hoffmann-La Roche | 100 | 2014-08-06 | 2020-04-24 |
| Comparison Among Erythropoietin Stimulating Agents Epoetin alpha or beta (Epoetin group), Darbepoetin alfa, Methoxy polyethylene glycol-epoetin beta - Anemia of End Stage Renal Disease | Phase 4 | Completed | Hamad Medical Corporation | 327 | 2012-03-01 | 2017-09-13 |
| Neocytolysis in the Treatment of Renal Anemia With Erythropoieses Stimulating Agents (ESA) cera, darbepoetin, epoetin-beta, ESA - Renal Anemia | Phase 4 | Completed | University Hospital, Basel, Switzerland | 9 | 2011-01-01 | 2011-10-19 |
| Study of Erythropoietin (EPO) Administration Schedule recomon (Epoetin Beta) - Chronic Renal Failure, Anaemia | Phase 4 | Completed | JW Pharmaceutical | 60 | 2009-10-01 | 2014-05-14 |
| A Study to Assess All-Cause Mortality and Cardiovascular Morbidity in Participants With Chronic Kidney Disease (CKD) on Dialysis and Those Not on Renal Replacement Therapy Receiving Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) or Reference Erythropoietin Stimulating Agents (ESAs) Darbepoetin Alfa, Epoetin Alfa, Epoetin Beta - Chronic Renal Anemia | Phase 4 | Completed | Hoffmann-La Roche | 2825 | 2008-12-12 | 2019-08-20 |
| High Dose Versus Standard Dose of Ribavirin in Patients With Chronic Hepatitis C, Genotype 3 Peginterferon alfa 2 A, Peginterferon alfa 2 A, ribavirin + Epo Beta, ribavirin - Chronic Hepatitis C | Phase 4 | Completed | Dr. Conrado Fernandez | 101 | 2008-11-01 | 2012-03-13 |
| A Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Chronic Hepatitis C. Pegasys, Ribavirin, epoetin beta [NeoRecormon] - Anemia | Phase 4 | Completed | Hoffmann-La Roche | 190 | 2008-03-01 | 2016-02-02 |
| Phase IV Study to Evaluate the Efficacy/Safety to Extend Treatment and High Dose of Ribavirin in co-Infected Patients ribavirin, Peginterferon alfa-2a, epoetin beta - Chronic Hepatitis C | Phase 4 | Unknown | Hospital Carlos III, Madrid | 384 | 2007-06-01 | 2009-01-29 |
| A Study of the Quality of Life and Treatment Response to Once Weekly Epoetin Beta (Recormon) Treatment in Anemic Participants With Solid and Lymphoid Malignancies Epoetin beta - Anemia | Phase 4 | Completed | Hoffmann-La Roche | 117 | 2007-01-01 | 2017-07-02 |
| COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia. darbepoetin alfa, epoetin beta [NeoRecormon] - Anemia | Phase 4 | Completed | Hoffmann-La Roche | 48 | 2006-09-01 | 2016-11-02 |
| A Study to Assess the Hematopoyetic Response of Anemic Patients With Hematologic Malignancies Treated With Erythropoietin B Epoetin Beta - Anemia | Phase 4 | Terminated | Hoffmann-La Roche | 4 | 2006-09-01 | 2016-11-02 |
| A Study of Recormon (Epoetin Beta) in Anemic Patients With Non-Myeloid Malignancy Epoetin Beta - Anemia | Phase 4 | Terminated | Hoffmann-La Roche | 10 | 2006-04-01 | 2016-11-02 |
| PROTECT: Prospective Trial on Erythropoietin in Clinical Transplantation Epoetin beta - Patients Receiving a Kidney From a Non-Heart-Beating Donor | Phase 4 | Completed | Leiden University Medical Center | 92 | 2005-07-01 | 2010-08-02 |
| A Study of Epoetin Beta (NeoRecormon) in Participants With Solid Tumors or Hematologic Malignancies Epoetin beta - Anemia | Phase 4 | Completed | Hoffmann-La Roche | 54 | 2005-02-01 | 2016-11-02 |
| A Study of Epoetin Beta (NeoRecormon) in Predialysis Patients With Renal Anemia Epoetin Beta - Anemia | Phase 4 | Completed | Hoffmann-La Roche | 58 | 2004-10-01 | 2016-11-02 |
| A Study of Epoetin Beta (NeoRecormon) in Participants With Solid Tumors Epoetin beta - Anemia | Phase 4 | Completed | Hoffmann-La Roche | 28 | 2004-06-01 | 2016-11-02 |
| Blood Management in Orthopedic Surgery erythropoietin and cell saver, erythropoietin, OrthoPAT - Osteoarthritis | Phase 4 | Completed | Sanquin Research & Blood Bank Divisions | 2598 | 2004-05-01 | 2009-10-20 |
Showing 20 of 25. Sign in to see all of them.
Anemia (19) · Hepatitis C, Chronic (2) · Kidney Diseases (2) · Delayed Graft Function (1) · Kidney Failure, Chronic (1) · Myelodysplastic Syndromes (1) · Osteoarthritis (1) · Renal Insufficiency (1) · Renal Insufficiency, Chronic (1) · Uterine Cervical Neoplasms (1)
Hoffmann-La Roche (13) · AGO Study Group (1) · Centre Hospitalier Universitaire, Amiens (1) · Dr. Conrado Fernandez (1) · Hamad Medical Corporation (1) · Hospital Carlos III, Madrid (1) · Hospital Son Espases (1) · Imperial College Healthcare NHS Trust (1) · Imperial College London (1) · JW Pharmaceutical (1) · Leiden University Medical Center (1) · Sanquin Research & Blood Bank Divisions (1) · University Hospital, Basel, Switzerland (1)
Spain (5) · Australia (3) · France (3) · Serbia (3) · Bulgaria (2) · Germany (2) · Netherlands (2) · Russia (2) · South Korea (2) · Thailand (2) · United Kingdom (2) · Venezuela (2) · Argentina (1) · Belgium (1) · Brazil (1)
Conrado M Fernandez-Rodriguez (1) · Damien Ashby, MBBS (1) · Damien Dr Ashby, MBBS (1) · Fadwa S. AL-Ali, MD (1) · Franck Martinez, MD, PhD (1) · Gabriel Choukroun, MD, PhD (1) · Heinz Koelbl, MD (1) · Michael Dickenmann, MD (1) · Miguel Uriol, Ph.D.M.D. (1) · Rob Nelissen, MD, PhD (1) · SugKyun Shin, Ph.D. (1) · Ton Rabelink, MD, PhD (1) · Vicente Soriano, Dr (1)
PMID 36791280, PMID 18565240, PMID 20377423, PMID 22193388, PMID 24360571, PMID 31420350